- Home
- CHE vs RVMD Comparison
CHE vs RVMD Comparison
Compare CHE & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHE
- RVMD
- Stock Information
- Founded
- CHE 1970
- RVMD 2014
- Country
- CHE United States
- RVMD United States
- Employees
- CHE N/A
- RVMD N/A
- Industry
- CHE Medical/Nursing Services
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHE Health Care
- RVMD Health Care
- Exchange
- CHE Nasdaq
- RVMD Nasdaq
- Market Cap
- CHE 8.8B
- RVMD 7.4B
- IPO Year
- CHE N/A
- RVMD 2020
- Fundamental
- Price
- CHE $574.85
- RVMD $39.40
- Analyst Decision
- CHE Buy
- RVMD Strong Buy
- Analyst Count
- CHE 1
- RVMD 12
- Target Price
- CHE $674.00
- RVMD $68.67
- AVG Volume (30 Days)
- CHE 125.7K
- RVMD 2.0M
- Earning Date
- CHE 07-23-2025
- RVMD 05-07-2025
- Dividend Yield
- CHE 0.35%
- RVMD N/A
- EPS Growth
- CHE 10.48
- RVMD N/A
- EPS
- CHE 20.53
- RVMD N/A
- Revenue
- CHE $2,488,997,000.00
- RVMD N/A
- Revenue This Year
- CHE $9.53
- RVMD N/A
- Revenue Next Year
- CHE $6.08
- RVMD $241.39
- P/E Ratio
- CHE $28.00
- RVMD N/A
- Revenue Growth
- CHE 8.52
- RVMD N/A
- 52 Week Low
- CHE $512.12
- RVMD $29.17
- 52 Week High
- CHE $623.61
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- CHE 50.36
- RVMD 51.81
- Support Level
- CHE $568.01
- RVMD $36.53
- Resistance Level
- CHE $581.20
- RVMD $40.00
- Average True Range (ATR)
- CHE 10.27
- RVMD 1.80
- MACD
- CHE 1.20
- RVMD -0.21
- Stochastic Oscillator
- CHE 72.80
- RVMD 47.28
About CHE Chemed Corp
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.